Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

A groundbreaking HIV cure trial conducted in Durban has demonstrated promising results in achieving antiretroviral therapy (ART)-free virus control. The trial shows that 20% of participants remain off ...

Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million ...

Vaccines, medications and other biomedical breakthroughs are necessary to eliminate epidemic diseases. But as I explore in my ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

As scientists gathered at the Conference for Retroviruses and Opportunistic Infections, or CROI, for meetings that run through Wednesday, they face an uncertain future. It was evident in who was ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are deemed to be at high risk of contracting the human immunodeficiency ...